MORGAN STANLEY - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTU and the CUSIP is G1125A124. A total of 35 filers reported holding BIOTECH ACQUISITION COMPANY in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$5,527
+10.5%
5510.0%0.00%
Q3 2022$5,000
-89.6%
551
-88.6%
0.00%
Q2 2022$48,000
-42.2%
4,847
-42.6%
0.00%
Q1 2022$83,000
-2.4%
8,4470.0%0.00%
Q4 2021$85,0000.0%8,4470.0%0.00%
Q3 2021$85,000
-15.0%
8,447
-14.9%
0.00%
Q2 2021$100,000
+2.0%
9,9220.0%0.00%
Q1 2021$98,0009,9220.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q3 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 12,968$1300.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 210$2,1060.00%
MILLENNIUM MANAGEMENT LLC 40,000$4010.00%
MORGAN STANLEY 551$5,5270.00%
Tower Research Capital LLC (TRC) 103$10.00%
View complete list of BIOTECH ACQUISITION COMPANY shareholders